Researchers found that proton pump inhibitors, which are drugs used to reduce gastric acid, could promote the growth of a type of bacteria associated with chronic liver diseases. Proton pump inhibitors (PPIs) are drugs that reduce the production of gastric, or stomach acid in the long-term. PPIs are often used to treat gastroesophageal reflux disease, which is a condition wherein gastric acid travels up to the esophagus, producing an uncomfortable burning sensation.To read the full story, visit: MedicalNewsToday
